Proton Pump Inhibitors, Dual Antiplatelet Therapy, and the Risk of Gastrointestinal Bleeding

被引:3
|
作者
Marlicz, Wojciech [1 ]
Loniewski, Igor [2 ]
Koulaouzidis, George [2 ]
机构
[1] Pomeranian Med Univ, Dept Gastroenterol, Unii Lubelskiej 1, PL-71252 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Biochem Sci, Szczecin, Poland
关键词
MYOCARDIAL-INFARCTION; ASSOCIATION; GUIDELINES; DISEASE;
D O I
10.1016/j.mayocp.2022.02.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:648 / 651
页数:4
相关论文
共 50 条
  • [21] The Risk of Gastrointestinal Bleeding Is Higher in Patients With Underlying Cirrhosis on Dual Antiplatelet Therapy
    Spence, Linsey
    Russo, Mark
    Benbow, Jennifer
    Padilla, Leybelis
    Anderson, William
    Schrum, Laura
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S533 - S534
  • [22] Etiology of gastrointestinal bleeding in patients on dual antiplatelet therapy
    Shaukat, Arslan
    Waheed, Salman
    Alexander, Ethan
    Washko, Daniel
    Dawn, Buddhadeb
    Olyaee, Mojtaba
    Gupta, Kamal
    JOURNAL OF DIGESTIVE DISEASES, 2018, 19 (02) : 66 - 73
  • [23] High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment
    Atay, Kadri
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (09) : 980 - 981
  • [24] Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding
    Tsai, Yi-Wen
    Wen, Yu-Wen
    Huang, Weng-Foung
    Chen, Pei-Fen
    Kuo, Ken N.
    Hsiao, Fei-Yuan
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (01) : 39 - 45
  • [25] Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding
    Yi-Wen Tsai
    Yu-Wen Wen
    Weng-Foung Huang
    Pei-Fen Chen
    Ken N. Kuo
    Fei-Yuan Hsiao
    Journal of Gastroenterology, 2011, 46 : 39 - 45
  • [26] The Prevention of Upper Gastrointestinal Bleeding Associated with Antiplatelet Therapy By Proton Pump Inhibitors (PPI). Results of a Nested Case-Control Study
    Bretagne, Jean-Francois
    Nalet, Bernard
    Lesur, Gilles
    Bour, Bruno
    Soufflet, Christine
    Barthelemy, Philippe
    GASTROENTEROLOGY, 2009, 136 (05) : A634 - A634
  • [27] Dual Antiplatelet Therapy and the Risk of Bleeding Reply
    Hansen, Morten Lock
    Gislason, Gunnar
    Torp-Pedersen, Christian
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (08) : 787 - 788
  • [28] Impact of proton pump inhibitors or famotidine on the antiplatelet actions during dual-antiplatelet therapy in Japanese patients
    Nagata Y.
    Inomata J.
    Kinoshita M.
    Kurokawa K.
    Aburadani I.
    Maruyama M.
    Usuda K.
    Cardiovascular Intervention and Therapeutics, 2013, 28 (1) : 22 - 29
  • [29] The association between proton pump inhibitors and the risk of gastrointestinal bleeding in oral anticoagulants users
    Zixuan Wang
    Qiuyan Yu
    Charlotte Warren-Gash
    Krishnan Bhaskaran
    Clémence Leyrat
    Ka Shing Cheung
    Celine S. L. Chui
    Esther W. Chan
    Ian C. K. Wong
    Amitava Banerjee
    Liam Smeeth
    Ian J. Douglas
    Angel Y. S. Wong
    npj Cardiovascular Health, 2 (1):
  • [30] Proton pump inhibitors and long-term risk of recurrent upper gastrointestinal bleeding
    Hsu, Y. -C.
    Lin, H. -J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (02) : 232 - 233